ArticleInternational urology and nephrology2017

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.

Kazuhisa Hagiwara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.